SCHEMBL2084797

SCHEMBL2084797

Cc1cc(Cl)cnc1CN(CCCCN(C)C(=O)OC(C)(C)C)Cc1nccc2ccccc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 4/20 0.36
GBA1 P04062 1/20 0.36
CHRM2 P08172 1/20 0.36
CHRM4 P08173 1/20 0.36
CHRM5 P08912 1/20 0.36
CHRM1 P11229 1/20 0.36
CHRM3 P20309 1/20 0.36
SSTR4 P31391 1/20 0.33
HTR2C P28335 1/20 0.32
SLC6A4 P31645 1/20 0.32
BACE1 P56817 1/20 0.32
PDK2 Q15119 1/20 0.32
TRPV4 Q9HBA0 1/20 0.32
S1PR3 Q99500 1/20 0.31
AURKA O14965 2/20 0.31
RPS6KB1 P23443 2/20 0.31
BCHE P06276 2/20 0.31
ACHE P22303 2/20 0.31
GLS O94925 1/20 0.31
MAPK1 P28482 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2085960 0.91 CXCR4 (0.38) CXCR4GBA1CHRM2CHRM4CHRM5
SCHEMBL2086441 0.86 CXCR4 (0.36) CXCR4CHRM2CHRM4CHRM5CHRM1
SCHEMBL2084795 0.80 GBA1 (0.33) GBA1TRPV4S1PR3AURKARPS6KB1
SCHEMBL2084424 0.79 SSTR4 (0.32) CXCR4SSTR4HTR2CSLC6A4TRPV4
SCHEMBL2082674 0.77 CXCR4 (0.41) CXCR4GBA1CHRM2CHRM4CHRM5
SCHEMBL2085676 0.77 CXCR4 (0.38) CXCR4CHRM2CHRM4CHRM5CHRM1
SCHEMBL2084600 0.74 MEN1 (0.42) ACHE
SCHEMBL2084235 0.73 BCHE (0.34) CHRM2SSTR4PDK2TRPV4S1PR3
SCHEMBL2084500 0.72 CXCR4 (0.36) CXCR4CHRM2CHRM4CHRM5CHRM1
SCHEMBL2085959 0.72 GBA1 (0.34) CXCR4GBA1TRPV4AURKARPS6KB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1613613-B1 CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS GENZYME CORP (US) 2021-06-02 EP disclosed
US-7863293-B2 CXCR4 chemokine receptor binding compounds GENZYME CORPORATION (US) 2011-01-04 US disclosed
EP-1613613-A4 CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS ANORMED INC (CA) 2009-03-25 EP disclosed
US-20080255197-A1 CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS ANORMED CORPORATION (CA) 2008-10-16 US disclosed
US-7291631-B2 CXCR4 chemokine receptor binding compounds GENZYME CORPORATION (US) 2007-11-06 US disclosed
EP-1613613-A2 CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS ANORMED INC. (CA) 2006-01-11 EP disclosed
WO-2004091518-A2 CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS ANORMED INC. (CA) 2004-10-28 WO disclosed
US-20040209921-A1 CXCR4 chemokine receptor binding comounds ANORMED CORPORATION (CA) 2004-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040209921-A1 CXCR4 chemokine receptor binding comounds CXCR4, CXCR1, CXCR3 CXCR4 1/4885GBA1 3802/4885CHRM2 785/4885
US-20080255197-A1 CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS CXCR4, CXCR1, CXCR3 CXCR4 1/4885GBA1 2788/4885CHRM2 655/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.